Dissociation of the effects of amylin on osteoblast proliferation and bone resorption

American Journal of Physiology - Endocrinology and Metabolism

Volumn 274, Issue 5 37-5, 1998, Pages

  Cornish, J ^a   Gallon, K E ^a   Lin, C Q X ^a   Xiao, C L ^a   Mulvey, T B ^b   Coy, D H ^c   Cooper, G J S ^a,b   Reid, I R ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c TULANE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Amylin molecular fragments; Amylin peptide blockers; Bone formation; Structure activity relationships

Indexed keywords

AMYLIN; CALCITONIN GENE RELATED PEPTIDE[8-37]; CALCITONIN RECEPTOR;

ANIMAL CELL; ARTICLE; BONE METABOLISM; CALVARIA; CARBOXY TERMINAL SEQUENCE; CATABOLISM; CELL PROLIFERATION; DISULFIDE BOND; FETUS; HUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION;

EID: 0031804596     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1998.274.5.e827     Document Type: Article

References (27)

1. Alam, A. S., B. S. Moonga, P. J. Bevis, C. L. Huang, and M. Zaidi. Amylin inhibits bone resorption by a direct effect on the motility of rat osteoclasts. Exp. Physiol. 78: 183-196, 1993.
2. Bikker, J. A., and C. Humblet. Ligand design for G-protein coupled receptors. In: Structure and Function of Seven Transmembrane Receptors, edited by T. W. Schwartz, S. A. Hjorth, and J. S. Kastrup. Copenhagen, Denmark: Munksgaard, 1996, p. 375-388.
3. Cooper, G. J. S. Amylin compared with calcitonin gene-related peptide-structure, biology, and relevance to metabolic disease. Endocr. Rev. 15: 163-201, 1994.
4. Cooper, G. J. S., A. C. Willis, A. Clark, R. C. Turner, R. B. Sim, and K. B. M. Reid. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc. Natl. Acad. Sci. USA 84: 8628-8632, 1987.
5. Cornish, J., K. Callon, G. J. S. Cooper, and I. R. Reid. The effect of amylin in neonatal mouse calvaria (Abstract). Bone Miner. 25, Suppl. 1: S41, 1994.
6. Cornish, J., K. E. Callon, G. J. S. Cooper, and I. R. Reid. Amylin stimulates osteoblast proliferation and increases mineralized bone volume in adult mice. Biochem. Biophys. Res. Commun. 207: 133-139, 1995.
7. Cornish, J., K. E. Callon, D. H. Coy, N.-Y. Jiang, L. Xiao, G. J. S. Cooper, and I. R. Reid. Adrenomedullin is a potent stimulator of osteoblastic activity in vitro and in vivo. Am. J. Physiol. 273 (Endocrinol. Metab. 36): E1113-E1120, 1997.
8. Datta, H. K., M. Zaidi, S. J. Wimalawansa, I. M. A. Ghatei, J. L. Beacham, S. R. Bloom, and I. MacIntyre. In vivo and in vitro effects of amylin and amylin-amide on calcium metabolism in the rat and rabbit. Biochem. Biophys. Res. Commun. 162: 876-881, 1989.
9. Gilbey, S. G., M. A. Ghatei, D. Bretherton-Watt, M. Zaidi, P. M. Jones, T. Perera, J. Beacham, S. Girgis, and S. R. Bloom. Islet amyloid polypeptide: production by an osteoblast cell line and possible role as a paracrine regulator of osteoclast function in man. Clin. Sci. (Colch.) 81: 803-808, 1991.
10. Groot, C. G., J. K. Danes, J. M. van der Meer, and M. P. M. Herrmann-Erlee. Osteocalcin antigenicity in cultured osteoblast-like cells after stimulation with 1,25-vitamin D3 (Abstract). Cell Biol. Int. 9: 528, 1985.
11. Heinrikson, R. L., and S. C. Meredith. Amino acid analysis by reverse-phase high-performance liquid chromotography: precolumn derivitization with phenylisothiocyanate. Anal. Biochem. 136: 65-74, 1984.
12. Herrmann-Erlee, M. P. M., and J. M. van der Meer. The effect of PTH and PGE2 on growth and differentiation of primary fetal rat osteblast-like cells, on UMR 106 osteosarcoma cells, and on a SV40 transformed "osteoblast-like" cell line. Int. Conf. IX Cal. Regul. Horm. Bone Metab. 1986, p. 409.
13. MacIntyre, I. Amylinamide, bone conservation, and pancreatic beta cells. Lancet 1: 1026-1027, 1989.
14. Miles, P. D. G., L. J. Deftos, A. R. Moossa, and J. M. Olefsky. Islet amyloid polypeptide (amylin) increases the renal excretion of calcium in the conscious dog. Calcif. Tissue Int. 55: 269-273, 1994.
15. Montuenga, L. M., A. Martinez, M. J. Miller, E. J. Unsworth, and F. Cuttitta. Expression of adrenomedullin and its receptor during embryogenesis suggests autocrine or paracrine modes of action. Endocrinology 138: 440-451, 1997.
16. Perlman, S., H. T. Schambye, R. A. Rivero, W. J. Greenlee, S. A. Hjorth, and T. W. Schwartz. Non-peptide angiotensin agonist: functional and molecular interaction with the AT 1 receptor. J. Biol. Chem. 270: 1493-1496, 1995.
17. Pietschmann, P., K. H. Farsoudi, O. Hoffmann, K. Klaushofer, H. Horandner, and M. Peterlik. Inhibitory effect of amylin on basal and parathyroid hormone-stimulated bone resorption in cultured neonatal mouse calvaria. Bone 14: 167-172, 1993.
18. Reid, I. R., R. Ames, M. C. Evans, S. Sharpe, G. Gamble, J. T. France, T. M. T. Lim, and T. F. Cundy. Determinants of total body and regional bone mineral density in normal postmenopausal women - a key role for fat mass. J. Clin. Endocrinol. Metab. 75: 45-51, 1992.
19. Reid, I. R., M. C. Evans, and R. W. Ames. Volumetric bone density of the lumbar spine is related to fat mass but not lean mass in normal postmenopausal women. Osteoporos. Int. 4: 362-367, 1994.
20. Reid, I. R., M. C. Evans, G. J. S. Cooper, R. W. Ames, and J. Stapleton. Circulating insulin levels are related to bone density in normal postmenopausal women. Am. J. Physiol. 265 (Endocrinol. Metab. 28): E655-E659, 1993.
21. Reid, I. R., M. Legge, J. P. Stapleton, M. C. Evans, and A. B. Grey. Regular exercise dissociates fat mass and bone density in premenopausal women. J. Clin. Endocrinol. Metab. 80: 1764-1768, 1995.
22. Reid, I. R., C. Lowe, J. Cornish, S. J. M. Skinner, D. J. Hilton, T. A. Willson, D. P. Gearing, and T. J. Martin. Leukemia inhibitory factor: a novel bone-active cytokine. Endocrinology 126: 1416-1420, 1990.
23. Reid, I. R., L. D. Plank, and M. C. Evans. Fat mass is an important determinant of whole body bone density in premenopausal women but not in men. J. Clin. Endocrinol. Metab. 75: 779-782, 1992.
24. Tamura, T., C. Miyaura, I. Owan, and T. Suda. Mechanism of action of amylin in bone. J. Cell. Physiol. 153: 6-14, 1992.
25. Thiebaud, D., T. Akatsu, T. Yamashita, T. Suda, T. Noda, R. E. Martin, A. E. Fletcher, and T. J. Martin. Structure-activity relationships in calcitonin gene-related peptide: cyclic AMP response in a preosteoblast cell line (KS-4). J. Bone Miner. Res. 6: 1137-1142, 1991.
26. Villa, I., A. Rubinacci, F. Ravasi, A. F. Ferrara, and F. Guidobono. Effects of amylin on human osteoblast-like cells. Peptides 18: 537-540, 1997.
27. Zaidi, M., V. S. Shankar, C. L. H. Huang, M. Pazianas, and S. R. Bloom. Amylin in bone conservation - current evidence and hypothetical considerations. Trends Endocrinol. Metab. 4: 255-259, 1993.